Metformina Zentiva

Metformin Hydrochloride, the active ingredient in Metformina Zentiva, is a biguanide presented as an oral tablet for oral use. It is employed to lower elevated blood glucose levels in adults with type 2 diabetes mellitus and is also indicated for gestational diabetes management, and may be used as part of a comprehensive lifestyle and dietary plan.

GNH USA supplies Metformina Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Metformina Zentiva (metformin) is used to improve glycemic control in disorders of glucose metabolism. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Gestational diabetes mellitus: helps achieve target glucose levels during pregnancy. - Prediabetes (impaired glucose tolerance): delays progression to overt diabetes when combined with lifestyle measures.

Metformina Zentiva may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools. - Abdominal discomfort: cramping or pain. - Metallic taste: transient alteration of taste. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: reduced absorption over long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: life‑threatening metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes. - Hypoglycemia: when combined with other glucose‑lowering agents. - Anemia: rare hematologic effect. - Pancreatitis: inflammation of the pancreas.

Metformina Zentiva should be used with attention to patient‑specific risk factors and clinical monitoring. - Renal function: assess eGFR before initiation and periodically thereafter. - Hepatic function: avoid in patients with significant liver disease. - Lactic acidosis risk: discontinue before major surgery or iodinated contrast studies. - Alcohol consumption: limit intake to reduce acidosis risk. - Pregnancy and breastfeeding: evaluate benefits versus risks with a healthcare professional. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformina Zentiva can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Iodinated contrast media: may precipitate lactic acidosis. - Alcohol: increases risk of metabolic acidosis. - Cimetidine: can raise metformin plasma concentrations.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors/ARBs: monitor renal function and potassium levels. - Other antidiabetic agents: adjust dose to avoid hypoglycemia. - Thyroid hormones: may alter glucose metabolism.